More articles from Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

You have access
Peptide receptor radiotherapy (PRRT) as a potential tool of neoadjuvant therapy in patients with inoperable neuroendocrine tumors (NETs)
Anna Sowa-Staszczak, Dorota Pach, Agnieszka Stefanska, Monika Tomaszuk, Renata Mikolajczak, Dariusz Pawlak, Malgorzata Trofimiuk, Robert Chrzan and Alicja Hubalewska-Dydejczyk

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1743;
You have access
Quantitative SPECT reconstructions for combined Lu-177/Y-90 radionuclide therapy: Phantom experiments
Sergey Shcherbinin, Hanna Piwowarska-Bilska, Josh Grimes, Anna Celler, Maria Listewnik, Piotr Zorga and Bozena Birkenfeld

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1745;
You have access
Preclinical evaluation of Sm-153-DOTMP as a therapeutic bone-seeking radiopharmaceutical
Jaime (Jim) Simon, R. Frank, Druce Crump, Jason Rogers, Shannon Phillips, Scot Ellebracht, Naoto Ueno and Richard Wendt

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1751;
You have access
Development of a thermosensitive hydrogel system for local delivery of radionuclide and chemotherapeutic drug in a hepatocellular carcinoma
Cheng-Liang Peng, Ying-hsia Shih, Tsai-Yueh Luo, Wuu-Jyh Lin, I-Chung Tang and Chung-Hsin Yeh

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1732;
You have access
Reliable index of tumor targeting in RIT with ¹⁷⁷Lu-J591 monoclonal antibody in patients with metastatic prostate cancer
Masaya Kawano, Joseph Osborne, Shankar Vallabhajosula, Scott Tagawa, Neil Bander and Stanley Goldsmith

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1758;
You have access
Survival predictors of intraperitoneal radioimmunotherapy for ovarian cancer
Ruby Meredith, Shouluan Ding, Ronald Alvarez, Edward Partridge and Albert LoBuglio

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1755;
You have access
Clinical feasibility of Lu-177 EDTMP prescribed bone marrow irradiation dose concept in bone pain palliation
John Zaknun, Chandrasekhar Bal, Shabana Saeed, Ghazal Jameel, Javier Gaudiano, Ahmad Qureshy, Claudio Traino and Giuliano Mariani

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1753;
You have access
Pharmacokinetics and dosimetry of the bone-seeking agent 177Lu-EDTMP in patients with metastatic prostate cancer
John Zaknun, Chandrasekhar Bal and Patrick Dupont

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1748;
You have access
Formulation of radioactive nanoparticles for therapy of neuroendocrine tumors: Encapsulation and in-vitro release kinetics
Geetanjali Arora, Jaya Shukla, Sourabh Ghosh, Arun Malhotra, Rakesh Kumar and Guru Bandopadhyaya

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1740;
You have access
Safety and efficacy of peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumor patients having single kidney or nonfunctional kidney
Vikas Prasad, Harshad Kulkarni, Carolin Zachert, Dieter Hoersch and Richard Baum

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1741;

Main menu

User menu

Search

More articles from Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

Pages